Release secondary endpoint data from the Phase 1b clinical trial
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 16 Feb 2021
- Due
- 30 Jun 2021
- Checked
- 25 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Evaluation of secondary endpoint data is ongoing and will be available early in the second quarter of 2021.”
What we found
Evidence strength A What the grades mean
The company did not release the secondary endpoint data for the Phase 1b COVID-19 trial by the stated deadline, and subsequent filings do not confirm the release of this specific data.
-
A Diffusion Pharmaceuticals Inc. 8-K filed 2021-06-30
“Particular risk and uncertainties include, among other things, those related to: the completion of the full analyses of the data from the TCOM Trial, including secondary endpoint data” ✓ confirmed on the page
-
A Diffusion Pharmaceuticals Inc. 10-Q filed 2021-08-11
“In May 2021, we announced final results of our COVID Trial” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Commercial launch
- Indicative materiality
- Medium rules
- Action
- Release
- Deliverable
- secondary endpoint data
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- Medium
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Met”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Diffusion Pharmaceuticals Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-CRVO-023892 · Corrections policy